Federal award
ROCHE DIAGNOSTICS CORPORATION
W58P0522C0010
Contract
Obligated and Ceiling
- Obligated (net)
- $569,500,000.00
- Ceiling (potential value, not spending)
- $569,500,000.00
- Current value
- $569,500,000.00
- Gross positive obligations
- $569,500,000.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- GENMARK DIAGNOSTICS INC. · ZKZ6C6X3XLD3
- Awarding agency
- Department of War · sub-agency 2100 · office W58P05
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W58P0522C0010
- Award type code
- D
- Actions
- 4 · Jan 13, 2022 to Feb 16, 2022
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 16, 2022 | FY2022 | P00003 | A | $212,500,000.00 | — |
| Feb 15, 2022 | FY2022 | P00001 | M | $0.00 | — |
| Feb 15, 2022 | FY2022 | P00002 | G | $17,000,000.00 | — |
| Jan 13, 2022 | FY2022 | 0 | — | $340,000,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.